BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ueda F, Sumi K, Tago K, Kasahara T, Funakoshi-tago M. Critical role of FANCC in JAK2 V617F mutant-induced resistance to DNA cross-linking drugs. Cellular Signalling 2013;25:2115-24. [DOI: 10.1016/j.cellsig.2013.07.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Funakoshi-tago M, Moriwaki T, Ueda F, Tamura H, Kasahara T, Tago K. Phosphorylated CIS suppresses the Epo or JAK2 V617F mutant-triggered cell proliferation through binding to EpoR. Cellular Signalling 2017;31:41-57. [DOI: 10.1016/j.cellsig.2016.12.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
2 Yao C, Du W, Chen H, Xiao S, Huang L, Chen F. The Fanconi anemia/BRCA pathway is involved in DNA interstrand cross-link repair of adriamycin-resistant leukemia cells. Leuk Lymphoma 2015;56:755-62. [PMID: 24996439 DOI: 10.3109/10428194.2014.935363] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
3 Funakoshi-Tago M, Tsukada M, Watanabe T, Mameda Y, Tago K, Ohe T, Nakamura S, Mashino T, Kasahara T. Effect of chemical modification on the ability of pyrrolidinium fullerene to induce apoptosis of cells transformed by JAK2 V617F mutant. Int Immunopharmacol 2014;20:258-63. [PMID: 24631513 DOI: 10.1016/j.intimp.2014.02.035] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
4 Hu Y, Hong Y, Xu Y, Liu P, Guo DH, Chen Y. Inhibition of the JAK/STAT pathway with ruxolitinib overcomes cisplatin resistance in non-small-cell lung cancer NSCLC. Apoptosis 2014;19:1627-36. [PMID: 25213670 DOI: 10.1007/s10495-014-1030-z] [Cited by in Crossref: 53] [Cited by in F6Publishing: 53] [Article Influence: 7.6] [Reference Citation Analysis]
5 Uchihara Y, Komori R, Tago K, Tamura H, Funakoshi-Tago M. Methotrexate significantly induces apoptosis by inhibiting STAT3 activation in NPM-ALK-positive ALCL cells. Biochem Pharmacol 2019;170:113666. [PMID: 31654627 DOI: 10.1016/j.bcp.2019.113666] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]